4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-23-021245
Principal Accounting Officer sold 210 shares at $3.31 ($695)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tourangeau Greg Principal Accounting Officer | 2023-05-10 | Sale | −210 | $3.31 | $695 | 15,992 | D: show line 1 in the form |
| Open-market sales · 210 sh · avg $3.31 · $695 | |||||||
Loading xslF345X04/ownership.xml…